MHUA

Meihua International Medical Technologies Co Ltd

MHUA, USA

Meihua International Medical Technologies Co., Ltd. engages in the research and development, manufacture, and sale of medical devices in the People's Republic of China. The company offers Class I disposable medical devices, including disposable medical X-ray films, medical dry films, dry laser imagers, gauze bandages, examination gloves, pharmaceutical packaging materials and containers, low-density polyethylene bottles for eye drops, and high-density polyethylene bottles for tablets; Class II products, such as disposable full anesthesia kits, medical brush, woman's examination kits, urethral catheterization kits, gynecological examination kits, endotracheal intubation, medical masks, anal bags, and suction connecting tube, etc.; and Class III disposable medical devices, such as disposable infusion pumps, anesthesia puncture kits, electronic pumps, etc. It also offers disposable plastic baby bottles, NB/PSN rubber covers and 8.2mL folded spoons for tools and containers, etc.; Class II 6866 medical polymer materials and products, including transfusion equipment and pipelines, endotracheal intubation for respiratory anesthesia or ventilation; and medical x-ray films and multi-functional self-extracting X-ray film machines. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China.

https://www.meihuamed.com

Stock Price

$0.00

0%

decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
MHUA
stock
MHUA

Aug Intraday: Will MHUA benefit from green energy policies - Analyst Downgrade & Free Verified High Yield Trade Plans baoquankhu1.vn

Read more →
MHUA
stock
MHUA

What consensus target says about MYO stock - July 2025 Chart Watch & Low Risk Entry Point Guides ulpravda.ru

Read more →

Showing 2 of 10

Finn Analysis

(Last Updated 2025-06-30)

Health Score

Price to Earnings Ratio (P/E)

-

Very High

0.25

Low ≥ 50

High ≤ 10

Price to Book Ratio (P/B)

-

Very Low

0.01

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

1.91 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

1.65 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-52.17 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very High

0.16

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 0.51% of the total shares of Meihua International Medical Technologies Co Ltd

1.

UBS Group AG

(0.2935%)

since

2025/06/30

2.

Renaissance Technologies Corp

(0.0755%)

since

2025/06/30

3.

TWO SIGMA SECURITIES, LLC

(0.0509%)

since

2025/06/30

4.

Geode Capital Management, LLC

(0.0451%)

since

2025/06/30

5.

Fidelity Nasdaq Composite Index

(0.0451%)

since

2025/07/31

7.

Jane Street Group LLC

(0%)

since

2025/06/30

8.

Two Sigma Investments LLC

(0%)

since

2025/06/30

9.

Virtu Financial LLC

(0%)

since

2025/03/31

10.

XTX Topco Ltd

(0%)

since

2025/06/30

11.

Citadel Advisors Llc

(0%)

since

2025/06/30

12.

HRT FINANCIAL LLC

(0%)

since

2025/03/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2025-06-30

EPS Actual

0.1

EPS Estimate

—

EPS Difference

0

Surprise Percent

0%

Investing Fit Scorecard

(Last Updated 2025-06-30)

Deep Value
Strong Deep Value(8)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Wide Moat Company(6.8)
GARP
Strong GARP(7)
Growth
Moderate Growth(5.5)
Momentum
Strong Momentum(8)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Moderate Quality(5)
Value
Undervalued(8)

Income Statement

(Last Updated 2025-06-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-06-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-06-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.